首页> 外文OA文献 >5PSQ-007 The pharmaceutical governance of low molecular weight heparins: appropriateness analysis

【2h】

5PSQ-007 The pharmaceutical governance of low molecular weight heparins: appropriateness analysis

机译：5PSQ-007低分子量肝素的药物治理：适当性分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
MR Garreffa; P Vitale; A De Franco Iannuzzi;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy of intracolonic administration of low-molecular-weight heparin CB-01-05, compared to other low-molecular-weight heparins and unfractionated heparin, in experimentally induced colitis in rat. [J] . Celasco G, Moro L, Bozzella R, Digestive Diseases and Sciences . 2008,第12期

机译：与其他低分子量肝素和普通肝素相比，结肠内施用低分子量肝素CB-01-05在大鼠实验性结肠炎中的功效。
2. Efficacy of Intracolonic Administration of Low-Molecular-Weight Heparin CB-01-05, Compared to Other Low-Molecular-Weight Heparins and Unfractionated Heparin, in Experimentally Induced Colitis in Rat [J] . Giuseppe Celasco, Luigi Moro, Roberta Bozzella, Digestive Diseases and Sciences . 2008,第12期

机译：与其他低分子肝素和普通肝素相比，低分子肝素CB-01-05结肠内给药对大鼠实验性结肠炎的疗效
3. P11?Are low molecular weight heparins being initiated, monitored and subsequently adjusted appropriately for paediatric patients? [J] . Colleen Duffy Archives of disease in childhood . 2020,第9期

机译：P11？是低分子量肝素进行，监测，随后适当调整儿科患者吗？
4. LC-MS analysis of the complete molecular weight distribution of low molecular weight heparins [C] . Joseph Zaia, Kshitij Khatri, Joshua Klein, ASMS Conference on Mass Spectrometry and Allied Topics . 2016

机译：低分子量肝素完全分子量分布的LC-MS分析
5. Measurements of low molecular weight fluorescent advanced glycation endproducts in serum: Limitations of flow injection analysis assays for the assessment of diabetic complications [D] . O'Keeffe, Elizabeth Kathryn 2006

机译：血清中低分子量荧光高级糖基化终产物的测定：流动注射分析法在糖尿病并发症评估中的局限性
6. Low molecular weight protamine as nontoxic heparin/low molecular weight heparin antidote (III): Preliminary in vivo evaluation of efficacy and toxicity using a canine model [O] . Li-Chien Chang, Shirley Wrobleski, Thomas W. Wakefield, 2001

机译：低分子量鱼精蛋白作为无毒肝素/低分子量肝素解毒剂（III）：使用犬模型对体内功效和毒性进行初步评估
7. PCV120 - INDICATORS OF PRESCRIPTIVE APPROPRIATENESS AS A LEVER FOR PHARMACEUTICAL SUSTAINABILITY - THE CASE OF LOW MOLECULAR WEIGHT HEPARINS [O] . M. Andretta, L. Degli Esposti 2018

机译：PCV120 - 作为药物可持续性的杠杆指标的指标 - 低分子量肝素的情况

5PSQ-007 The pharmaceutical governance of low molecular weight heparins: appropriateness analysis

著录项

引文网络

相似文献

相关主题

期刊订阅